Zoetis, Inc.
(NYSE : ZTS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
ZTSZoetis, Inc. -0.17%186.131.9%$339.09m
TEVATeva Pharmaceutical Industries Ltd. -2.36%10.162.0%$73.11m
JAGXJaguar Health, Inc. -2.14%1.640.9%$31.80m
KINKindred Biosciences, Inc. 0.27%9.220.2%$22.62m
RDYDr. Reddy's Laboratories Ltd. -0.61%71.652.0%$7.59m
TXMDTherapeuticsMD, Inc. -2.48%1.1815.3%$5.88m
COCPCocrystal Pharma, Inc. 2.31%1.330.0%$5.18m
ABEOAbeona Therapeutics, Inc. -3.22%1.663.7%$2.10m
TAROTaro Pharmaceutical Industries Ltd. -1.11%74.006.5%$2.01m
CPHIChina Pharma Holdings, Inc. -0.01%0.720.1%$1.23m
LFVNLifeVantage Corp. -3.26%7.413.4%$0.49m

Company Profile

Zoetis, Inc. discovers, develops, and manufactures a portfolio of animal health medicines and vaccines. The firm operates through the following segments: United States &International. Its products are complemented by diagnostic products, genetic tests, bio devices, and services. These are designed to meet the needs of veterinarians and the livestock farmers and companion animal. The company provides its services though five categories namely, anti-invectives, vaccines, parasitic ides, medicated feed additives, and other pharmaceuticals. Zoetis was founded in 1952 and is headquartered in Parsippany, NJ.